FDA May Begin to Keep a More Vigilant Watch

The FDA has been under heavy scrutiny as of late due to many high profile events in the news. The FDA has taken heat on everything from Vioxx to contaminated pet food. Last Wednesday the Senate approved decision to monitor side effects more closely in order to decrease the number of high profile drug failures. In the case of Vioxx, many felt that the pain medication remained on the market to long before being voluntarily removed by its makers in 2004 after tests it doubled the risk of heart attacks and strokes. According to MSNBC, “The Senate legislation, approved on a 93-1 vote, would require the Food and Drug Administration to actively monitor the safety of drugs on the market and require pharmaceutical companies to develop plans to manage any serious risks assoc View the rest of this article